BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17032401)

  • 1. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
    Day CP
    Liver Int; 2006 Nov; 26(9):1021-8. PubMed ID: 17032401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
    Wilfred de Alwis NM; Day CP
    Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
    Järveläinen HA; Orpana A; Perola M; Savolainen VT; Karhunen PJ; Lindros KO
    Hepatology; 2001 May; 33(5):1148-53. PubMed ID: 11343243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of genes in nonalcoholic fatty liver disease.
    Day CP
    Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG
    Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.
    Valenti L; De Feo T; Fracanzani AL; Fatta E; Salvagnini M; Aricò S; Rossi G; Fiorelli G; Fargion S
    Alcohol Alcohol; 2004; 39(4):276-80. PubMed ID: 15208156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of alcoholic liver disease.
    Stickel F; Hampe J
    Gut; 2012 Jan; 61(1):150-9. PubMed ID: 22110053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease.
    Osterreicher CH; Halangk J; Berg T; Patsenker E; Homann N; Hellerbrand C; Seitz HK; Eurich D; Stickel F
    Cytokine; 2008 Apr; 42(1):18-23. PubMed ID: 18337117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts in the pathogenesis of alcoholic liver disease.
    Albano E
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):749-59. PubMed ID: 19090736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
    Nezi V; Deutsch M; Gazouli M; Alexopoulou A; Paparrigopoulos T; Liappas IA; Dourakis SP
    Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
    Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.